Skip to content

Clinical trials

Phase 1/2 Adrenoleukodystrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenoleukodystrophy Phase: Phase 1/2 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated2
Completed1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeuroVia, Inc.1
Shenzhen Second People's Hospital1
SwanBio Therapeutics, Inc.1
Talaris Therapeutics Inc.1
University of Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenoleukodystrophy5
Leukodystrophy, Metachromatic2
Mucopolysaccharidosis I2
Adrenal Insufficiency1
Anemia, Diamond-Blackfan1
Anemia, Hemolytic1
Anemia, Sickle Cell1
Bone Marrow Failure Disorders1
Brain Diseases, Metabolic1
Brain Diseases, Metabolic, Inborn1

Trials

Showing 51 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.